Literature DB >> 10614663

Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells.

A Martínez1, S Kapas, M J Miller, Y Ward, F Cuttitta.   

Abstract

Three receptors have been characterized by their ability to bind adrenomedullin (AM): L1, RDC1, and CRLR. Immunohistochemical analysis and RT-PCR showed that all three receptors are expressed by the insulin-producing cells of the islets of Langerhans. RDC1 and CRLR in the presence of particular modifying proteins can also bind calcitonin gene-related peptide (CGRP). Such data suggest that the inhibitory effect caused by both AM and CGRP on insulin secretion is mediated by a direct interaction with the beta-cell. We also identified receptors for amylin, the third member of the AM peptide family, in mouse insulin-secreting cells. The beta-cells located closer to the periphery of the islets had a stronger immunoreactivity for the AM/ CGRP receptors. This observation could be related to a paracrine mechanism, given the proximity of AM- and CGRP-secreting cells (F and delta-cells, respectively), which are located at the periphery of the islets. Interestingly, the smooth muscle cells in the pancreatic vasculature expressed only RDC1, which is in agreement with physiological data showing that AM functions in the cardiovascular system are mainly mediated through a CGRP1 receptor. These data further implicate AM and the other components of its peptide family as important regulators of insulin release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10614663     DOI: 10.1210/endo.141.1.7261

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

2.  Plasma procalcitonin and risk of type 2 diabetes in the general population.

Authors:  A Abbasi; E Corpeleijn; D Postmus; R T Gansevoort; P E de Jong; R O B Gans; J Struck; H L Hillege; R P Stolk; G Navis; S J L Bakker
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

Review 3.  Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.

Authors:  Sanghamitra Singh; Saurabh Trikha; Diti Chatterjee Bhowmick; Anjali A Sarkar; Aleksandar M Jeremic
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 4.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 5.  The Molecular Physiopathogenesis of Islet Amyloidosis.

Authors:  Diti Chatterjee Bhowmick; Sanghamitra Singh; Saurabh Trikha; Aleksandar M Jeremic
Journal:  Handb Exp Pharmacol       Date:  2018

6.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.

Authors:  L'Houcine Ouafik; Samantha Sauze; Françoise Boudouresque; Olivier Chinot; Christine Delfino; Frédéric Fina; Vincent Vuaroqueaux; Christophe Dussert; Jacqueline Palmari; Henri Dufour; François Grisoli; Pierre Casellas; Nils Brünner; Pierre-Marie Martin
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers.

Authors:  Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Indian J Gastroenterol       Date:  2012-12-16

Review 8.  The role of stromal-derived factor-1--CXCR7 axis in development and cancer.

Authors:  Radoslaw B Maksym; Maciej Tarnowski; Katarzyna Grymula; Joanna Tarnowska; Marcin Wysoczynski; Riu Liu; Boguslaw Czerny; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

9.  The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.

Authors:  Vijaya Ramachandran; Thiruvengadam Arumugam; Robert Langley; Rosa F Hwang; Pablo Vivas-Mejia; Anil K Sood; Gabriel Lopez-Berestein; Craig D Logsdon
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.

Authors:  Gina Ryan; Tim A Briscoe; Lynette Jobe
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.